PARP1 and plasma cell myeloma: A recent GEP study has demonstrated that increased expression of PARP1 is associated with shortened survival in myeloma patients [104], whereas another GEP study identified the gene as one of 15 which may be used as an expression signature to define high-risk disease [105].